MAP kinases: Differential activation following in vivo and ex vivo irradiation

Molecular and Cellular Biochemistry

Volumn 294, Issue 1-2, 2007, Pages 65-72

  Mitra, Anirban Kumar ^a   Singh, Rakesh Kumar ^a   Krishna, Malini ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Exvivo; In vivo; P38MAPK; p44 42MAPK; SAPK and lymphocytes

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EX VIVO STUDY; FEMALE; GAMMA IRRADIATION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LYMPHOCYTE; MOUSE; NONHUMAN; SWISS WEBSTER MOUSE;

ANIMALS; ENZYME ACTIVATION; GAMMA RAYS; LYMPHOCYTES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RADIATION DOSAGE; WHOLE-BODY IRRADIATION;

EID: 33846681853     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9246-z     Document Type: Article

References (41)

1. Lewanski CR, Gullick WJ: Radiotherapy and cellular signaling. Lancet Oncology 2: 366-370, 2001
2. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S: MAPK pathways in radiation responses. Oncogene 22: 5885-96, 2003
3. Mordret G: MAA kinase kinase: a node connecting multiple pathways. Biol Cell 79: 193-207, 1993
4. Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117-122, 1995
5. Kennedy JS, Raab M, Rudd CE: Signaling scaffolds in immune cells. Cell Calcium 26: 227-235, 1999
6. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL: Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47: 185-201, 2000
7. Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D, Zhang XF: Ras activation of the RaT kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 56: 127-155, 2001
8. Chakraborty P: G-protein-mediated signaling and its control in macrophages and mammalian cells. Crit Rev Microbiol 27: 1-8, 2001
9. Pierce KL, Luttrell LM, Lefkowitz RJ: New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532-1539, 2001
10. Haddad JJ, Saade NE, Safieh-Garabedian B: Interleukin-10 and the regulation of mitogen-activated protein kinases: Are these signalling modules targets for the anti-inflammatory action of this cytokine? Cell Signal 15: 255-267, 2003
11. Yang SH, Sharrocks AD, Whitmarsh AJ: Transcriptional regulation by the MAP kinase signaling cascades. Gene 320: 3-21, 2003
12. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001
13. Pouyssegur J, Volmat V, Lenormand P: Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem Pharmacol 64: 755-763, 2002
14. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P: Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Current Biol 5: 283-295, 1995
15. Camps M, Nichols A, ArkinAtall S: Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14: 6-16, 2000
16. Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Current Opinion in Cell Biology 12: 186-192, 2000
17. English JM, Cobb MH: Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23: 40-45, 2002
18. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K: Signal transduction and cellular radiation responses. Radiat Res 153: 245-257, 2000
19. Shonai T, Adachi M, Sakata K, Takekawa M, Endo T, Imai K, Hareyama M: MEK/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells. Cell Death Differ 9: 963-971, 2002
20. Shimizu T, Kato Jr T, Tachibana A, Sasaki MS: Coordinated regulation of radioadaptive response by protein kinase C and p38 mitogen-activated protein kinase. Exp Cell Res 251: 424-432, 1999
21. Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D: Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res 61: 7689-7696, 2001
22. Lee YJ, Soh JW, Jeoung DI, Cho CK, Jhon GJ, Lee SJ, Lee YS: PKC epsilon-mediated ERK1/2 activation involved in radiation-induced cell death in NIH3T3 cells. Biochim Biophys Acta 1593: 219-229, 2003
23. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R, Gopalkrishnan RV, Grant S, Fisher PB, Dent P: Mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2: 347-353, 2003
24. Kametani Y, Goto H, Kobori A, Sato T, Ando K, Hozumi K, Nishimura T, Saito T, Yamamoto T, Habu S: Ex vivo evidence for asymmetric tyrosine phosphorylation of ZAP-70 on double-positive thymocytes in the positive selection process. Int Immunol 10: 1203-1210, 1998
25. Wen BG, Pletcher MT, Warashina M, Choe SH, Ziaee N, Wiltshire T, Sauer K, Cooke MP: Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Proc Natl Acad Sci USA 101: 5604-5609, 2004
26. Amdjadi K, Sefton BM: Ultraviolet light-induced stimulation of the JNK mitogen-activated protein kinase in the absence of src family tyrosine kinase activation. J Biol Chem 275: 22520-22525, 2000
27. Alonso A, Saxena M, Williams S, Mustelin T: Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J Biol Chem 276: 4766-4771, 2001
28. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M: Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res 59: 2457-2463, 1999
29. 2-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation. Cell Signal 13: 645-652, 2001
30. Carter AB, Monick MM, Hunninghake GW: Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 18: 384-391, 1998
31. Weichselbaum RR, Hallahan D, Fuks Z, Kufe D: Radiation induction of immediate early genes: Effectors of the radiation-stress response. Int J Radiat Oncol Biol Phys 30: 229-234, 1994
32. Varadkar PA, Krishna M, Verma NC: Dose-dependent differential expression of protein kinase C isozymes in mouse lymphocytes after gamma irradiation in vivo and ex vivo. Radiat Res 159: 453-457, 2003
33. Bernard F, Jaleco S, Dardalhon V, Steinberg M, Yssel H, Noraz N, Taylor N, Kinet S: Ex vivo isolation protocols differentially affect the phenotype of human CD4+ T cells. J Immunol Methods 271: 99-106, 2002
34. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 16: 2787-2796, 1998
35. Vrana JA, Grant S, Dent P: Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation. Radiat Res 151: 559-569, 1999
36. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kiRase pathways: regulation and physiological functions. Endocrine Rev 22: 153-183, 2001
37. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Advances in Cancer Research 74: 49-139, 1998
38. Boehm JC, Bower MJ, Gallagher TF, Kassis S, Johnson SR, Adams JL: Phenoxypyrimidine inhibitors of p38alpha kinase: Synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles. Bioorg Med Chem Lett 11: 1123-1126, 2001
39. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chemi 273: 18623-18632, 1998
40. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000
41. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS: C-Jun N- terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108: 73-81, 2001